/Investor DB

Eos Advisory — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Carcinotech.Cocarcinotech.co.ukinDec 2023

Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesScotland, GB

Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)Lorna(Chief Scientific Officer)Susanne

Wobble Genomicswobblegenomics.cominDec 2023

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.

BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh

Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)

Co-investorsIQ CapitalMercia VenturesOld College Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.